Anti-IL17A (Cosentyx) (secukinumab biosimilar) mAb
Product Sizes
50 µg
£478.00
12-9156-50UG
100 µg
£550.00
12-9156-100UG
About this Product
- SKU:
- 12-9156
- Additional Names:
- CTLA-8;CTLA8;IL-17;IL-17A;IL17
- Clonality:
- Monoclonal
- Extra Details:
- Secukinumab (Cosentyx) is a biologic medication used to treat psoriatic arthritis; moderate to severe plaque psoriasis. Biologics are medicines that are human-made through genetic engineering techniques and closely related to a protein that occurs naturally in the body. Secukinumab blocks an inflammatory protein called IL-17; thus improving joint pain and swelling from arthritis and rash from psoriasis. Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Isotype:
- IgG1
- Purification:
- Purified from cell culture supernatant by affinity chromatography
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- Store at -20[o]C to -80[o]C for 12 months in lyophilized form. After reconstitution; if not intended for use within a month; aliquot and store at -80[o]C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature.
- Supplier:
- Abeomics
- Type:
- Antibodies:Monoclonal Antibody
- Manufacturer's Data Sheet:12-9156 -FLOW.jpg
